Related Experiment Video
Updated: Jul 4, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Editorial Commentary: Clinical Trial Subgroup Analyses and Investigation of Secondary Outcome Measures Should Be
Abstract:
Large randomized clinical trials are our highest quality evidence. Performing subgroup analyses and analysis of secondary outcome measures can and should be done to increase the scientific yield of these expensive and difficult studies. However, caution must be maintained when dramatic or unexpected outcomes are achieved. If we perform a large number of subgroup analyses and these are independent of each other, the risk of false-positive findings increases.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Assumptions of Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Longitudinal Research
Hazard Ratio
For example, in a clinical trial...

